Editorial on Translational Research in Graft-Versus-Host Disease (GVHD) and Graft-Versus-Tumor (GVT) Effect After Allogeneic Hematopoietic Cell Transplantation

Front Immunol. 2022 Jun 8:13:948720. doi: 10.3389/fimmu.2022.948720. eCollection 2022.

Marie Czech^{1

2}, Robert Zeiser^{1

3

4}, Tomomi Toubai⁵

¹ Department of Medicine I, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
² Faculty of Biology, University of Freiburg, Freiburg, Germany.
³ Signaling Research Centre for Biological Signalling Studies (BIOSS) Freiburg and CIBSS - Centre for Integrative Biological Signalling Studies, University of Freiburg, Freiburg, Germany.
⁴ Comprehensive Cancer Center Freiburg (CCCF), Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
⁵ Department of Internal Medicine III, Division of Hematology and Cell Therapy, Faculty of Medicine, Yamagata University, Yamagata, Japan.

No abstract available

Keywords: GvHD; GvT effect; JAK - STAT signaling pathway; allogeneic hematologic stem cell transplantations; mesenchymal stem cell.

Publication types